Claritev Corp at Q&A Webcast Hosted by Nephron Research Transcript
Greetings, and welcome to the Nephron Research Q&A with Claritev. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Josh Raskin of Nephron Research. Thank you, Josh. You may begin.
I appreciate everyone dialing in this morning, super excited to host the Claritev team. We've got the whole team here. We've got Travis Dalton, the CEO; Doug Garis, the CFO; and Jerry Hogge, the COO, as well. I'm going to turn it over to Todd Friedman, who coordinates the Investor Relations for a little bit of a safe harbor. And then we're going to go through some Q&A as we get through there.
I think we're going to try and clear up some lingering questions post the quarter and hopefully, everyone finds is super helpful. So with that, I'll turn it over to Todd.
Thanks, Josh. I want to first say thank you to you and to Nephron for allowing us to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
